Dr. Faheem Ahmed, M.D. Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2000 Medical Dr, Lakeway, TX 78734 Phone: 512-000-0000 |
News Archive
It is not the amount of time spent sitting still that matters. Instead, it is the extent of physical activity that is essential in reducing the risk of elderly women developing cardiovascular disease, as shown in a new örebro study published in PLOS ONE.
Preoperative chemotherapy is a feasible option for resectable advanced colon cancer, show results of the FoXTROT trial.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical needs and commercial potential. Palatin's lead product under development is bremelanotide for the treatment of female sexual dysfunction (FSD).
A March 29 symposium at the New York Academy of Sciences, "Vaccines Under the Gun: Politics, Science, Media and the Law," will feature a presentation by Daniel J. Thomasch, JD, national lead trial counsel for Wyeth, who was involved in the case decided by the Supreme Court yesterday in which the justices rejected a lawsuit claiming injury from a Wyeth vaccine.
The U.S. Food and Drug Administration today approved Brisdelle (paroxetine) to treat moderate to severe hot flashes (vasomotor symptoms) associated with menopause. Brisdelle, which contains the selective serotonin reuptake inhibitor paroxetine mesylate, is currently the only non-hormonal treatment for hot flashes approved by the FDA.
› Verified 7 days ago